Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial adhesion sites and biofilm-associated surface structures represent a diverse class of molecular targets critical for the initiation and persistence of bacterial infections. These structures include adhesins, pili, fimbriae, and the extracellular polymeric substances (EPS) that constitute the biofilm matrix (Nature Reviews Microbiology, 2017). Their primary biological function is to facilitate the attachment of bacteria to host tissues or abiotic surfaces, such as medical implants, and to provide a protective environment against host immune responses and antibiotics (Frontiers in Microbiology, 2020). In clinical settings, these structures are central to the pathogenesis of chronic infections, including cystic fibrosis, urinary tract infections, and device-related complications (Microbiology and Molecular Biology Reviews, 2019). Therapeutic strategies targeting these sites often involve competitive inhibitors, such as mannosides, or monoclonal antibodies designed to block attachment or disrupt the structural integrity of the biofilm (ClinicalTrials.gov). By preventing colonization and biofilm maturation, these agents aim to reduce bacterial virulence and enhance the efficacy of traditional antimicrobial treatments. However, the high diversity and redundancy of these structures across different bacterial species present significant challenges for broad-spectrum drug development.
Competitive inhibition of bacterial adhesins, disruption of extracellular matrix components, and inhibition of pili/fimbriae assembly.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial adhesion sites and biofilm-associated surface structures.